Acasti Pharma (ACST)

$2.85 0.00 (0.00%)
9:30 EDT ACST Stock Quote Delayed 30 Minutes

The Future Doesn’t Look Too Bright For Acasti Pharma Stock

Following unsuccessful Phase 3 clinical trial results for its core CaPre treatment, Acasti and ACST stock look doomed.

Acasti’s Losing Drug and ACST Stock Are Not for Weak Hearts

Does Acasti Stock Have a Future?

The Future of ACST Stock Is on Hold

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 127.15M
PE Ratio -3.85
EPS -0.74
Volume (Avg. Vol.) 168
Day's Range $2.85 - $2.85
52-Week Range $1.72 - $3.84
Dividend & Yield N/A (N/A)